US 7829561
Caspase inhibitors and uses thereof
granted A61PA61P1/04A61P1/16
Quick answer
US patent 7829561 (Caspase inhibitors and uses thereof) held by Vertex Pharmaceuticals Incorporated expires Mon Nov 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Nov 09 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61P, A61P1/04, A61P1/16, A61P1/18, A61P11/06